TIM3 expression is associated with glioblastoma cells resistance to temozolomide therapy, moreover, its use leads to an increase in TIM3 expression; at the same time, suppression of TIM3 expression is associated with higher level of apoptosis [55]. Here, HAVCR2 is linked to glioblastoma.